Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by LithLoveron Feb 04, 2022 10:45am
91 Views
Post# 34397478

RE:RE:RE:RE:RE:RE:Warrant Extension

RE:RE:RE:RE:RE:RE:Warrant ExtensionThe warrants that are being extended are some of those that are expiring in 2022.  These are not the tradeable  szls.wt or szls.ws warrants.  Those don't expire until June 2023 and Dec 2023 respectively.

This is a good sign.  No risk and when the share price increases above the warrant price the warrants will be purchased adding cash to the coffers.  A better way than going for another round of financing if the company feels the share price is going to exceed those levels in the short term.



MarketMoney wrote: Also if you look at the shareprice vs the warrants........it's more cheaper to buy the stock than the warrants. Then again, warrant can go beserk and increase just because people wants them...not because it's cheap but because the investor wants them more than the seller wants them sold....That's the market, you never know what going to happen...otherwise it would be too easy lol


<< Previous
Bullboard Posts
Next >>